Sodum Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 1.00 M
as on 15-12-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 484.77%
(FY 2022)
- Profit 258.71%
(FY 2022)
- Ebitda 419.07%
(FY 2022)
- Net Worth 55.15%
(FY 2022)
- Total Assets 175.77%
(FY 2022)
About Sodum Drugs And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Keerthi Vallur, Sreelakshmi Siddavatam, Venkataramanareddy Sodum, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2017PTC120559
- Company No.
120559
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sodum Drugs And Pharmaceuticals?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Keerthi Vallur  | Director | 27-Mar-2021 | Current |
| Sreelakshmi Siddavatam | Director | 10-Nov-2017 | Current |
| Venkataramanareddy Sodum | Director | 10-Nov-2017 | Current |
| Srinivasa Gangineni | Director | 27-Mar-2021 | Current |
| Subhashini Daggubati | Director | 27-Mar-2021 | Current |
| Vijaya Angadala | Director | 27-Mar-2021 | Current |
Financial Performance of Sodum Drugs And Pharmaceuticals.
Sodum Drugs And Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 484.77% increase. The company also saw a substantial improvement in profitability, with a 258.71% increase in profit. The company's net worth Soared by an impressive increase of 55.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sodum Drugs And Pharmaceuticals?
In 2022, Sodum Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sree Vishnu Organicsciences Private LimitedActive 4 years 4 months
Keerthi Vallur, Srinivasa Gangineni and 1 more are mutual person
- Staychem Life Sciences Private LimitedActive 2 years 10 months
Sreelakshmi Siddavatam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sodum Drugs And Pharmaceuticals?
Sodum Drugs And Pharmaceuticals has a workforce of 32 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sodum Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sodum Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.